Purine-Scaffold Hsp90 Inhibitors
- 1 November 2009
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 9 (15) , 1436-1446
Abstract
Hsp90 is a molecular chaperone with important roles in regulating the function of several proteins with potential pathogenic activity. Because many of these proteins are involved in cancer and neurodegenerative promoting pathways, Hsp90 has emerged as an attractive therapeutic target in these diseases. Molecules that bind to the N-terminal nucleotide pocket of Hsp90 inhibit its activity, and consequently, disrupt client protein function. A number of these inhibitors from several chemical classes are now known, and some are already in clinical trials. This review focuses on the purine class of Hsp90 inhibitors, their discovery through rational design, and on efforts aimed towards their optimization and development into clinically viable drugs for the treatment of cancer. Their potential towards neurodegenerative diseases will also be touched upon.Keywords
This publication has 47 references indexed in Scilit:
- Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer modelsProceedings of the National Academy of Sciences, 2009
- Discovery and development of heat shock protein 90 inhibitorsBioorganic & Medicinal Chemistry, 2009
- Synthesis of Hsp90 inhibitor dimers as potential antitumor agentsBioorganic & Medicinal Chemistry, 2008
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and MetastasisCancer Research, 2008
- Structural and Quantum Chemical Studies of 8-Aryl-sulfanyl Adenine Class Hsp90 InhibitorsJournal of Medicinal Chemistry, 2006
- Targeting chaperones in transformed systems – a focus on Hsp90 and cancerExpert Opinion on Therapeutic Targets, 2006
- Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90Chemistry & Biology, 2004
- Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 IsoformsChemistry & Biology, 2004
- Adenine derived inhibitors of the molecular chaperone HSP90—SAR explained through multiple X-ray structuresBioorganic & Medicinal Chemistry Letters, 2004
- Development of a Purine-Scaffold Novel Class of Hsp90 Binders that Inhibit the Proliferation of Cancer Cells and Induce the Degradation of Her2 Tyrosine KinaseBioorganic & Medicinal Chemistry, 2002